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Abstract: Two new cyclohexyltin N-(salicylidene)valinates, [2
-HOC6H4CH=NCH(CH(CH3)2)COO]SnCy3 (1) and [2-
OC6H4CH=NCH(CH(CH3)2)COO]SnCy2 (2) (Cy = cyclohex-
yl), have been synthesized and characterized by elemental anal-
ysis, IR, and 1H NMR. The crystal structure of 2 has been deter-
mined by X-ray single crystal diffraction. In the complexes, the 
carboxylate is monodentate. Complex 1 is a four-coordinated tin 
compound, and 2 has a distorted trigonal bipyramidal geometry 
with the axial locations occupied by one carboxylate oxygen 
and a phenolic oxygen of the ligand. Bioassay results show that 
1 and 2 have good in vitro antibacterial activity against Esche-
richia coli. 
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1. INTRODUCTION 
Organotin carboxylates have been received considerable atten-
tion due to their structural interest and various applications in 
the last few decades [1-3]. Some organotin carboxylates possess 
potent activities against tumours, fungi, bacteria, and other mi-
croorganisms [3-6]. Recently, it has been reported that the or-
ganotin complexes of Schiff bases have antitumour, antimicro-
bial, antinematicidal, anti-insecticidal and anti-inflammatory 
activities [7,8]. N-Salicylidene-a-amino acid derived from salic-
ylaldehyde and a-amino acid is a very versatile ligand having an 
imine (Schiff base) and a carboxyl group and its organotin com-
plexes have been reported by several groups [9-16]. Structural 
studies have shown that the diorganotin complexes adopt isolat-
ed monomeric structures with the tin atom in a distorted trigonal 
bipyramid and the dimeric, trimeric and polymeric structures 
with the tin atom in a distorted octahedron in solid state [9-14], 
and triorganotin complexes possess [R3O2Sn] trigonal bipyrami-
dal geometry [15,16]. Bioassay studies showed that the organ-
otin complexes have significant cytotoxic and antibacterial ac-
tivities [12-16]. In theses investigations [9-17], the more atten-
tion was paid to the n-butyl- and phenyltin complexes, and the 
less to the cyclohexyltin complexes. In order to continue to ex-
pand the chemistry and therapeutic potential of the organotin 
complexes of the ligand, we synthesized two new cyclohexyltin 
N-(salicylidene)valinates, [2-HOC6H4CH=NCH(CH(CH3)2)
COO]SnCy3 (1) and [2-OC6H4CH=NCH(CH(CH3)2)COO]
SnCy2 (2) (Scheme 1),  and determined their in vitro antibacteri-
al activity against Escherichia coli.  
 Scheme 1.  Synthesis of the complexes. 
 
2. EXPERIMENTAL 
2.1 Materials and physical measurements 
All chemicals were of reagent grade and were used without fur-
ther purification (Sinopharm Chemical Reagent Company Lim-
ited, Shanghai, China). Carbon, hydrogen and nitrogen analyses 
were determined using a Perkin Elmer 2400 Series II elemental 
analyzer. IR spectra were recorded on a Nicolet 470 FT-IR 
spectrophotometer using KBr discs in the range 4000-400 cm-1. 
1H NMR spectral data were collected using a Bruker Avance 
DPX300 NMR spectrometer with CDCl3 as solvent and tetra-
methylsilane (TMS) as internal standard.  
 
2.2 Synthesis of the ligand 
 
At room temperature, potassium hydroxide (0.224 g, 4 mmol) 
and L-valine (0.468 g, 4 mmol) were added in methanol (60 
mL), and a methanolic solution (20 mL) of salicylaldehyde 
(0.488 g, 4 mmol) was added dropwise under stirring. The stir-
ring was continued for 0.5 h at 60 °C. The yellow solution ob-
tained was concentrated to about 15 mL under reduced pressure, 
and then 60 mL anhydrous diethylether was slowly added. The 
yellow precipitates afforded were filtered out. The yield of prod-
uct is 0.321 g (62%) after drying for 24 h in vacuum. m.p.: 170-
171 °C. Anal. Calcd. for C12H14KNO3: C, 55.57; H, 5.44; N, 
5.40%. Found: C, 55.46; H, 5.27; N, 5.32. IR (KBr) cm-1: 3419 
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(broad, O-H), 1644 [(COO)as], 1612 (C=N), 1395 [(COO)s], 
1217 (Ar-O).  
 
2.3 Synthesis of the complexes 
2. 3.1 Synthesis of complex 1 
 
A methanol solution (20 mL) of potassium N-(salicylidene)
valinate (0.518 g, 2 mmol) was added dropwise to a methanol 
solution (20 mL) of tricyclohexyltin chloride (0.808 g, 2 mmol) 
under stirring. The reaction mixture was refluxed for 2 h, and 
then the solvent was removed using a rotary evaporator. The 
residue was dissolved in dichloromethane and filtered after 
washed by using hot hexane. The yellow oil was obtained by the 
removal of solvent under reduced pressure, and washed with 
cold methanol and dried in vacuum for 24 h. Yield 0.872 g 
(74%). Anal. Calcd. for C30H47NO3Sn: C, 61.24; H, 8.05; N, 
2.38. Found: C, 61.31; H, 7.98; N, 2.41%. IR (KBr) cm-1: 3410 
(broad, O-H), 1662 [(COO)as], 1610 (C=N), 1385 [(COO)s], 
1285 (Ar-O). 1H NMR (CDCl3) d: 1H NMR 0.97 (d, J = 7.2 
Hz, 3H, CH3), 1.01 (d, J = 7.2 Hz, 3H, CH3), 1.25～1.95 (m, 33 
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H, 3Cy), 2.36～2.46 (m, 1H, CH), 3.84 (d, J = 5.2 Hz, 1H, 
=NCH), 6.58 (t, J = 7.5 Hz, 1H, H-5 of benzene ring) , 6.77 (d, J 
= 7.5 Hz, 1H, H-3 of benzene ring) , 6.88-7.10 (m, 2H, H-4 and 
H-6 of benzene ring), 8.16 (s, 1H, CH=N), 14.72 (s, 1H, OH).  
 
2.3.2 Synthesis of complex 2 
 
A methanol solution (20 mL) of dicyclohexyltin dichloride 
(0.712 g, 2 mmol) was added dropwise to a methanol solution 
(20 mL) of potassium N-(salicylidene)valinate (0.518 g, 2 
mmol) and Et3N (0.202 g, 2 mmol) under stirring. The reaction 
mixture was heated under reflux for 2 h, and the solvent was 
then removed using a rotary evaporator. The residue was dissol-
ved in dichloromethane and filtered after being washed by using 
hot hexane. The yellow solid was obtained by the removal of 
solvent under reduced pressure, and recrystallized from met-
hanol and dried in vacuum. Yield 0.842 g (78%), m.p. 196-197°
C. Anal. Calcd. for C24H35NO3Sn: C, 57.17; H, 7.00; N, 2.78%. 
Found: C, 57.09; H, 6.94; N, 2.77. IR (KBr) cm-1: 1672 [(COO)
as], 1604 (C=N), 1420 [(COO)s], 1300 (Ar-O). 1H NMR d: 
1.04 (d, J = 6.9 Hz, 3H, CH3), 1.11 (d, J = 6.8 Hz, 3H, CH3), 
Table 1. Crystallographic and refinement data of 2 
Empirical formula C24H35NO3Sn 
Formula weight 504.22 
Crystal system Orthorhombic 
Space group P212121 
a / Å 9.8298(17) 
b / Å 10.4736(19) 
c / Å 23.118(4) 
Volume / Å 3 2380.1(7) 
Z 4 
Dc / (g×cm
-3) 1.407 
m / mm-1 1.097 
F(000) 1040 
q range / (°) 1.76 to 26.00 
Crystal size / mm 0.16´0.10´0.09 
Reflections collected/unique 18338 / 4679(Rint= 0.0582) 
Reflections with I>2s(I) 3542 
GOF on F2 
Flack parameter 
1.009 
-0.04(4) 
R indices [I>2s(I)] R=0.045, wR=0.085 
R indices (all data) R=0.065, wR=0.093 
Dρmin, Dρmax / (e×nm
-3) -0.353, 0.580 
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2.26～2.30 (m, 1H, CH), 1.27～2.14 (m, 22H, 2Cy), 3.84 (d, J 
= 5.1 Hz, 3JSn-H = 36.6 Hz, 1H, =NCH), 6.77 (t, J = 7.5 Hz, 
1H, H-5 of benzene ring) , 6.84 (d, J = 7.5 Hz, 1H, H-3 of ben-
zene ring) , 7.21 (d, J = 7.5 Hz, 1H, H-6 of benzene ring), 7.45 
(t, J = 7.5 Hz, 1H, H-4 of benzene ring), 8.20 (s, 3JSn-H = 40.8 
Hz, 1H, CH=N).  
 
2.4 X-ray crystallography 
 
The yellow single crystal of 2 was obtained from dichloromet-
hane/n-hexane (2:1, V/V) by slow evaporation at room tempera-
ture. Diffractions measurements were performed on a Bruker 
Smart Apex imaging-plate area detector fitted with graphite 
monochromatized Mo-Ka radiation (0.71073 Å) using the j and 
w scan technique. The structures were solved by direct-methods 
and refined by a full-matrix least squares procedure based on F2 
using SHELXL-97 [18]. The non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were placed at calculated 
positions in the riding model approximation. In 2, a cyclohexyl 
(C(7)-C(12)) was disordered over two conformations, the site 
occupancies were refined to 0.55(4):0.45(4). Crystal data, colle-
ction procedures and refinement results are shown in Table 1. 
The crystallographic data has been deposited with the Cambrid-
ge Crystallographic Data Centre as supplementary publication 
number CCDC 1473499. 
 
3. RESULTS AND DISCUSSION 
 
Complexes 1 and 2 were synthesized by the reaction of tricyclo-
hexyltin chloride or dicyclohexyltin dichloride with potassium 
N-(salicylidene)valinate derived from the condensation of salic-
ylaldehyde and L-valine in the presence of KOH in 1:1 molar 
ratio (Scheme 1). The complexes are yellow oil or solids that 
are soluble in common organic solvents such as benzene, chlo-
roform, methanol, acetone and tetrahydrofuran. 
The ligand and complex 1 both show a strong band at ~3400 cm
-1 assigned to v(O–H×××N) (Scheme1). In 2 this band disap-
pears, indicting the deprotonation of phenolic oxygen of the 
ligand upon complexation with the tin atom. In 1 and 2, the 
bands appearing at 1662, 1672 cm-1 and 1385, 1420 cm-1 are 
assigned to νas(COO) and νs(COO), respectively. The difference 
between νas(COO) and νs(COO) bands, Δν(COO), is indicative 
of the coordination mode of the carboxylate to tin [20]. The Δν
(COO) value is 277 cm-1 for 1 and 252 cm-1 for 2, which is larg-
er than 200 cm-1, suggesting that the carboxylate is coordinated 
to tin in a monodentate mode [20]. In the ligand, and 1 and 2, 
the v(C=N) band appears as a single sharp band at ~1610 cm-1 
due to the O–H×××N=C intramolecular hydrogen bond and 
C=N → Sn coordination [9, 15].  
In 1H NMR spectra of 1, the single resonance of phenolic O–H 
is observed at 14.72 ppm because the action of intramolecular 
O–H×××N=C hydrogen bond makes H shift to N atom, while 
the signal of OH does not appear in 2, which indicates the re-
placement of OH proton by the cyclohexyltin moiety on com-
plex formation. In 1 and 2, the signal assigned to azomethine 
proton (CH=N) and methine proton (=N–CH) appears at ~8.20 
and ~3.84 ppm, respectively. The spin-spin coupling of the 
CH=N proton with tin nucleus (3J, 40.8 Hz) and =N–CH proton 
with tin nucleus (3J, 36.6 Hz) are observed in 2, and are not in 
1, which proves that there is CH=N→Sn coordination in 2, and 
is not in 1. 
The molecular structure of 2 is shown in Figure 1, and selected 
geometric parameters are given in Table 2. Complex 2 crystal-
lizes in chiral space group P212121 , and the coordination geom-
etry of the tin atom is a distorted trigonal bipyramid with two 
carbons (C(1) and C(7)) of cyclohexyl groups and a N(1) atom 
from the ligand defining the trigonal plane and a phenolic O(1) 
and a carboxylic O(2) atom occupying the axial positions. The 
tin atom forms a five- and a six-membered chelate rings with 
the ONO tridentate ligand. The two chelate rings both are not 
planar as seen in the following torsion angles Sn(1)-N(1)-C(20)
-C(21) (20.02(2)°) and Sn(1)-O(1)-C(13)-C(18) (-31.31(2)°). 
The five-membered ring formed by the N(1)-C(20)-C(21)-O(2)-
Sn(1) fragment has the C(20) atoms out of the mean planes by 
0.121(4) Å. With respect to the six-membered ring defined by 
the O(1)-C(13)-C(18)-C(19)-N(1)-Sn(1) fragment, the maxi-
mum deviation from the mean plane at O(1) atom is 0.263(5) Å. 
The bond distance of Sn(1)-O(2) is longer than that of Sn(1)-O
(1). The bond angle of the axial positions, O(1)-Sn(1)-O(2) 
(156.54(15)°), is similar to those of the reported analogues such 
as Ph2Sn(3,5-Br2-2-OC6H2CH=NCH(i-Pr)COO) (158.03(10)°) 
[13] and  
Bu2Sn(3,5-Br2-2-OC6H2CH=NCH(i-Pr)COO) (155.1(3)°) [21]. 
Three angles in the NC2 equatorial plane are in the range of 
115.5(3)-122.2(2)°. The tin atom is 0.090(2) Å out of the NC2 
trigonal plane in the direction of the more tightly held O(1) at-
om. Distortions from the ideal geometry may be rationalized 
partly by the restricted bite angles (O(1)-Sn(1)-N(1), 82.17(16)° 
and O(2)-Sn(1)-N(1), 74.41(16)°) of the tridentate ligand. The 
monodentate mode of coordination of carboxylate is also re-
flected in the disparate C(21)-O(2) and C(21)-O(3) bond 
Table 2.  Growth rate constants (μ) at different concentrations (C) of 1 and 2.  
1               
C (µg/ml) 1.28 2.56 3.84 5.12 6.40 7.68 8.96 
µ (min-1) 0.02302 0.02112 0.02087 0.01904 0.01691 0.01668 0.01481 
2               
C (µg/ml) 1.05 2.10 3.15 4.20 5.25 6.30 7.35 
µ (min-1) 0.03087 0.03004 0.02632 0.02372 0.02112 0.01960 0.0159 
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lengths of 1.287(7) and 1.206(7) Å, respectively.  
The antibacterial activity of the complexes and the reference 
drug (penicillin sodium and cefazolin sodium) was listed in Ta-
ble 4. The results showed that the complexes against Escherich-
ia coli are active and comparable with the reported tricyclohex-
yltin 2-phenyl-1,2,3-triazole-4-carboxylates (MIC 13.50 μg/mL) 
[22] , and dicyclohexyltin N-(3,5-dibromosalicylidene)valinate 
(MIC 38.63 μg/mL) [21]. The activity of 1 is stronger than that 
of 2, which may be due to the existence of triorganotin moiety 
in 1. They can be considered as anti-bacterial compounds to 
further study and modified although the activity of the comple-
xes is lower than that of the reference drugs. 
Table 3. Selected bond lengths (Å) and angles (°) for  2  
Sn(1)-O(1) 
Sn(1)-O(2) 
Sn(1)-N(1) 
2.104(4) 
2.151(4) 
2.169(4) 
Sn(1)-C(1) 
Sn(1)-C(7) 
  
 2.139(5) 
2.119(7) 
  
O(1)-Sn(1)-C(1) 
O(1)-Sn(1)-C(7) 
C(1)-Sn(1)-C(7) 
O(1)-Sn(1)-O(2) 
C(1)-Sn(1)-O(2) 
95.2(2) 
99.5(3) 
121.7(3) 
156.54(15) 
96.1(2) 
C(7)-Sn(1)-O(2) 
O(1)-Sn(1)-N(1) 
C(1)-Sn(1)-N(1) 
C(7)-Sn(1)-N(1) 
O(2)-Sn(1)-N(1) 
91.9(2) 
82.17(16) 
122.2(2) 
115.5(3) 
74.41(16) 
Table 4.  Antibacter ial activity (MIC, μg/mL) of the complexesa 
Complex 1 2 
Penicillin  
sodium 
cefazolin  
sodium 
Escherichia  
coli 
14.84 23.11 
 
8.03 
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